These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4351839)

  • 1. [Bacteriocin production linked to the presence of a plasmid, in Clostridium perfringens, type A].
    Ionesco H; Bouanchaud DH
    C R Acad Hebd Seances Acad Sci D; 1973 May; 276(20):2855-7. PubMed ID: 4351839
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmid detection in a bacteriocinogenic strain of Clostridium perfringens.
    Li AW; Krell PJ; Mahony DE
    Can J Microbiol; 1980 Aug; 26(8):1018-22. PubMed ID: 6257358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a bacteriocinogenic plasmid in Clostridium perfringens CW55.
    Mihelc VA; Duncan CL; Chambliss GH
    Antimicrob Agents Chemother; 1978 Nov; 14(5):771-9. PubMed ID: 215082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification of two plasmids isolated from a bacteriocinogenic strain of Clostridium perfringens].
    Ionesco H; Bieth G; Dauguet C; Bouanchaud D
    Ann Microbiol (Paris); 1976 Oct; 127B(3):283-94. PubMed ID: 190933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of bacteriocins from Clostridium perfringens by treatment with mitomycin C.
    Mahony DE
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1067-8. PubMed ID: 195516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment and application of a bacteriocin typing scheme for Clostridium perfringens.
    Watson GN
    J Hyg (Lond); 1985 Feb; 94(1):69-79. PubMed ID: 2857743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriocin susceptibility of Clostridium perfringens: a provisional typing schema.
    Mahony DE
    Appl Microbiol; 1974 Aug; 28(2):172-6. PubMed ID: 4368445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further development of a bacteriocin typing system for Clostridium perfringens.
    Scott HG; Mahony DE
    J Appl Bacteriol; 1982 Dec; 53(3):363-9. PubMed ID: 6302063
    [No Abstract]   [Full Text] [Related]  

  • 9. [The induced production of bacteriocin and bacteriophage by the BP6K-N-5 strain of "Clostridium perfringens" (author's transl)].
    Ionesco H; Wolff A; Sebald
    Ann Microbiol (Paris); 1974; 125B(3):335-46. PubMed ID: 4377069
    [No Abstract]   [Full Text] [Related]  

  • 10. [The mode of action of bacteriocin N5 purified from Clostridium perfringens].
    Ionesco H; Wolff A
    C R Acad Hebd Seances Acad Sci D; 1975 Dec; 281(24):2033-6. PubMed ID: 177225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of Clostridium perfringens and its L form to bacteriocins of C. perfringens.
    Mahony DE
    Can J Microbiol; 1982 Sep; 28(9):1032-6. PubMed ID: 6291734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible welchihin activity of Clostridium perfringens type A enterotoxin.
    Torres-Anjel MJ; Riemann HP
    Rev Latinoam Microbiol; 1976; 18(2):61-3. PubMed ID: 190663
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characterization of plasmid DNA in a lecithinase-positive and in a lecithinase-negative strain of Clostridium perfringens (author's transl)].
    Krämer J; Schallehn G
    Zentralbl Bakteriol Orig A; 1978 Oct; 241(4):438-47. PubMed ID: 216187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of two bacteriocins produced by Clostridium perfringens.
    Higa A; Yoshida E; Miyoshi Y
    Microbiol Immunol; 1991; 35(6):411-21. PubMed ID: 1921758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene.
    Garnier T; Cole ST
    J Bacteriol; 1986 Dec; 168(3):1189-96. PubMed ID: 2877971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on bacteriocinogeneity in Clostridium perfringens type A. I. Isolation of bacteriocines and their antibacterial spectrum.
    Tubylewicz H
    Bull Acad Pol Sci Biol; 1966; 14(1):31-6. PubMed ID: 4287552
    [No Abstract]   [Full Text] [Related]  

  • 17. Strain differentiation of Clostridium perfringens by bacteriocin typing, plasmid profiling and ribotyping.
    Schalch B; Eisgruber H; Schau HP; Wiedmann M; Stolle A
    Zentralbl Veterinarmed B; 1998 Dec; 45(10):595-602. PubMed ID: 9916550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of bacteriocin 28 produced by Clostridium perfringens.
    Li AW; Verpoorte JA; Lewis RG; Mahony DE
    Can J Microbiol; 1982 Jul; 28(7):860-73. PubMed ID: 6293695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ruminococcin C, a new anti-Clostridium perfringens bacteriocin produced in the gut by the commensal bacterium Ruminococcus gnavus E1.
    Crost EH; Ajandouz EH; Villard C; Geraert PA; Puigserver A; Fons M
    Biochimie; 2011 Sep; 93(9):1487-94. PubMed ID: 21586310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium perfringens--specific lysin.
    Nakamura S; Okada I; Mizuno J; Nishida S
    Can J Microbiol; 1977 May; 23(5):601-6. PubMed ID: 17459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.